SARC has today launched a new resource for patients and
caregivers, helping to facilitate access to expert sarcoma
programs for more accurate, timely, and informed diagnoses and
treatments for rare and ultrarare connective tissue
cancers.
ANN
ARBOR, Mich., May 8, 2024
/PRNewswire/ -- SARC (Sarcoma Alliance for Research Through
Collaboration) is proud to announce the launch of the Sarcoma
Centers Registry https://sarctrials.org/sarcoma-centers/, a
comprehensive, global resource facilitating informed patient
decision-making via access to specialized clinical programs expert
in the diagnosis and treatment of sarcoma.
SARC has today launched a new resource for
patients to streamline access to expert sarcoma centers
worldwide.
As the care of patients with cancer, particularly uncommon
cancers such as sarcoma, becomes increasingly complex and
therapeutic options become more nuanced, access to expert
clinicians is more critical than ever for optimal
decision making by the patients and caregivers. Sarcoma is a rare
and heterogeneous group of cancers of connective tissues that
comprise nearly 20% of childhood cancers and 1% of adult
cancers.
Centers included in the Sarcoma Centers Registry must apply and
be determined to have met qualifying criteria. With dozens of
sarcoma programs already accepted, SARC invites all sarcoma
programs from around the globe to apply for
listing—https://sarctrials.org/apply/.
"In 2023 SARC celebrated two decades of fostering collaborative
efforts to advance breakthroughs in sarcoma," said Steven Young, President & CEO of SARC, "and
the Sarcoma Centers Registry was developed to serve as tool to help
enable sarcoma patients access to more accurate and timely
diagnoses and treatments, while complementing our scientific
research initiatives."
For more information, please email
sarcomacenters@sarctrials.org, or call 1-734-930-7600, extension
3.
About SARC
SARC (Sarcoma Alliance for Research Through Collaboration) is a
US-based, non-profit (501(c)(3)) sarcoma research consortium solely
dedicated to fostering progress in the prevention and treatment of
sarcoma to improve patient outcomes and ultimately find a cure.
SARC was formed in 2003 by the sarcoma research community to
bring together the best cancer centers in the world supported by
centralized infrastructure for the conduct of multi-institutional
collaborative sarcoma research.
SARC has successfully established itself as a leader in
providing a unified platform for sarcoma experts to collaborate and
fast-track more dozens of Phase I-III clinical trials (with SARC as
regulatory sponsor) across close to 100 medical centers with
specialized sarcoma programs in the
United States and globally.
What Is Sarcoma?
Sarcomas are cancers of the bony skeleton (the skull, vertebrae,
ribs, and extremities), and the so-called soft tissues, including
muscle and fat. Sarcomas are disproportionately common in children
and young adults but occur at all ages. There are many different
types of sarcomas, leading to diagnostic and therapeutic
challenges. SARC and our collaborators are working to advance the
science and treatment of sarcomas.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/sarc-launches-global-sarcoma-centers-registry-supporting-patient-and-clinician-access-to-programs-expert-in-the-diagnosis-and-treatment-of-sarcoma-rare-and-ultrarare-cancer-types-comprising-15-20-of-childhood-cancers-and-1-of-a-302140529.html
SOURCE SARC